CClinicalTrials.gg
Status unknownNCT05189626Updated Jan 12, 2022

Effectiveness of Kaltenborn Mobilizations Versus Muscle Energy Technique in Adhesive Capsulitis.

An interventional study of Muscle energy technique and Kaltonborn mobilizations in Adhesive Capsulitis of Shoulder, sponsored by Health Education Research Foundation (HERF). Status unknown at 1 site in Pakistan. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2022-01-12.

Sponsored by Health Education Research Foundation (HERF) · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

Total of 30 patients are selected according to inclusion criteria by convenient sampling and randomly allocated by sealed envelop method into two groups. Group 1 is treated with Muscle energy technique(Post isometric relaxation) and Group 2 is treated with Grade II,III Kaltenborn mobilizations and both groups also receives conventional therapy in form of Codman exercise and Wall ladder exercises.Data will be collected at baseline then after 2 weeks and after 4 weeks of intervention.

Read the detailed description

The purpose of study is to determine effectiveness of muscle energy techniques(Post Isometric relaxation) and Kaltenborn mobilizations and to compare the effectiveness of both techniques on pain and functional disability in patients with Adhesive capsulitis.Several studies about the effects of Maitland mobilizations and Muscle energy technique have been conducted. Evidence regarding the comparison of Kaltenborn mobilizatuons and post isometric relaxation is sparse. There has been no work regarding effectiveness of these two techniques in improving pain and functional disability in patients of Adhesive capsulitis.

Kaltonborn Mobilizations involves the application of a passive sustained stretch technique to enhance joint mobility without articular surface suppression. The forces applied to increase joint mobility are graded from I-III. Grade I applies a distraction of minor intensity that hardly causes stress within the joint capsule; it is often used to decrease pain. Grade II refers to a force that stretches the periarticular tissue; such stimulus is colloquially referred to as "taking up the slack." Finally, Grade III force causes enough distraction or gliding so that joint capsule can sufficiently stretch; it is often used for enhancing ROM.

MET is unique in its application as the client provides the initial effort while the practitioner facilitates the process. One of the main uses of this method is to normalize joint range, rather than increase flexibility, and techniques can be used on any joints with restricted Range of Motion (ROM) identified during the passive assessment. The main effects of MET can be explained by two distinct physiological processes: Post Isometric Relaxation (PIR) and Reciprocal Inhibition (RI). Post isometric contraction decrease muscle tone in single group of muscle after brief period of submaximal isometric contraction of same muscle.

02

Conditions studied

  • Adhesive Capsulitis of Shoulder

Browse trials for

Keywords

  • Adhesive Capsulitis,Mobilizations, muscle energy technique
03

In context

Bursitis

411 studies on the registry are indexed under Bursitis; 112 are open to participants now.

This study's planned enrollment of 30 is below the median of 45 across 371 interventional studies indexed under Bursitis.

Browse Bursitis studies →

Lead sponsor

Health Education Research Foundation (HERF) is the lead sponsor of 15 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age between 20 and 60 years.
  • Duration of complaint for more than 3 months.
  • Gender: Both Male and Female.
  • Patients with idiopathic frozen shoulder
  • Patients having restriction in more than 2 ranges
  • Patients with diabetes

Exclusion criteria

Exclusion Criteria:

  • Shoulder dislocation, fracture or labral tear.
  • Shoulder girdle motor control deficit associated with neurological disorder.
  • Any bony deformities acquired or congenital in glenohumeral joint.
  • Patients with language barrier.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Group A

    Muscle energy technique

    Other: Muscle energy technique

  • Experimental
    Group B

    Kaltonborn mobilizations

    Other: Kaltonborn mobilizations

Interventions

  • OtherMuscle energy technique

    Post Isometric relaxation(muscle energy technique) 3 days/ week for 4 weeks

  • OtherKaltonborn mobilizations

    Kaltonborn mobilizations grade II and III will be performed on Glenohumeral joints 3 days/ week for 4 weeks.

06

What researchers measure

Primary outcomes

  1. Shoulder pain and disability index

    Shoulder pain and disability index is used to measure pain and functional disability level. Total scores range from 0 to 130 with a percentage score of 0 indicating less shoulder disability and 100 indicating more shoulder dysfunction

    Time frame: 4 weeks

  2. Universal goniometer

    universal goniometer is used to measure shoulder range of motion.

    Time frame: 4 weeks

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 12, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05189626
Lead sponsor
Health Education Research Foundation (HERF)
Responsible party
Sponsor
First posted
Jan 12, 2022
Start date
Dec 6, 2021
Primary completion
Mar 31, 2022 (estimated)
Completion
Mar 31, 2022 (estimated)
Last update
Jan 12, 2022

Study contacts

Waqar Ahmed Awan, PhD
Contact
president@herf.org.pk
+923335348846
Waqar Ahmed Awan, PhD
Contact
ce@trjournal.org
+923335348846
Aqsa Anwar, DPT
principal investigator · Rawalpindi Medical College

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion